Here are four points:
1. The stock is down 2.54 percent from 4.29 million shares.
2. AmSurg has declined 7.84 percent since July 9, 2015..
3. The company has a market cap of $3.83 billion.
4. Of the 13 analysts covering the stock, 11 rate it “buy,” one rates it “sell” and another one analyst rates it “hold.”
More articles on ASC issues:
10 key thoughts on private practice profitability
5 statistics on accountable care organizations — 500 & counting
6 statistics on ophthalmologist income, assets & life goals
